Bristol-Myers Squibb | BMY - Выручка от реализации

Биржевая цена
57.59
Изменение за день
-0.67 -1.15%
Ежемесячно
-3.58%
Ежегодный
14.72%
Q2 прогноз
57.45




Продажи Изменить Дата
AbbVie USD 15B 1.62B 2026-03
Abbott USD 11.16B 300M 2026-03
ALKERMES USD 384.5M 9.7M 2025-12
Amgen USD 9.9B 340M 2025-12
AstraZeneca USD 15.29B 213M 2026-03
Biogen USD 2.25B 30M 2026-03
Bristol-Myers Squibb USD 12.5B 300M 2025-12
Coherus Biosciences USD 12.75M 1.18M 2025-12
Drreddys Laboratories INR 87.27B 1.82B 2025-12
Eli Lilly USD 19.3B 1.7B 2025-12
Gilead Sciences USD 7.93B 130M 2025-12
GlaxoSmithKline GBP 7.63B 991M 2026-03
J&J USD 24.1B 500M 2026-03
Medtronic USD 9B 39M 2026-01
Merck USD 16.4B 880M 2025-12
Novartis USD 13.11B 226M 2026-03
Novo Nordisk DKK 79.14B 4.16B 2025-12
Perrigo USD 1.11B 70M 2025-12
Pfizer USD 17.58B 880M 2025-12
Phibro Animal Health USD 373.91M 10.02M 2025-12
Prestige Brands USD 283.44M 9.34M 2025-12
Regeneron Pharmaceuticals USD 3.6B 280M 2026-03
Roche Holding CHF 15.65B 274.5M 2025-12
Sanofi EUR 11.24B 60M 2026-03
Sanofi EUR 12.14B 65M 2026-03
United Therapeutics USD 790.2M 9.3M 2025-12
Zoetis USD 2.4B 0 2025-12